Your browser doesn't support javascript.
loading
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Sartor, Oliver; Coleman, Robert; Nilsson, Sten; Heinrich, Daniel; Helle, Svein I; O'Sullivan, Joe M; Fosså, Sophie D; Chodacki, Ales; Wiechno, Pawel; Logue, John; Widmark, Anders; Johannessen, Dag Clement; Hoskin, Peter; James, Nicholas D; Solberg, Arne; Syndikus, Isabel; Vogelzang, Nicholas J; O'Bryan-Tear, C Gillies; Shan, Minghua; Bruland, Øyvind S; Parker, Christopher.
Afiliação
  • Sartor O; Tulane Cancer Center, New Orleans, LA, USA. Electronic address: osartor@tulane.edu.
  • Coleman R; Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK.
  • Nilsson S; Karolinska University Hospital, Radiumhemmet, Stockholm, Sweden.
  • Heinrich D; Akershus University Hospital, Department of Oncology, Lørenskog, Norway.
  • Helle SI; Haukeland University Hospital, Bergen, Norway.
  • O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
  • Fosså SD; Oslo University Hospital, Radiumhospital, Oslo, Norway.
  • Chodacki A; Hospital Chomutov, Nuclear Medicine Department, Chomutov, Czech Republic.
  • Wiechno P; Centrum Onkologii-Instytut im Marii Skodowskiej-Curie, Warsaw, Poland.
  • Logue J; Christie Hospital, Manchester, UK.
  • Widmark A; Umeå University, Department of Radiation Sciences, Oncology, Sweden.
  • Johannessen DC; Ullevål University Hospital, Oslo, Norway.
  • Hoskin P; Mount Vernon Hospital Cancer Centre, Northwood, Middlesex, UK.
  • James ND; Cancer Research Unit, University of Warwick, Coventry, UK; University Hospital, Birmingham NHS Trust, Birmingham, UK.
  • Solberg A; St Olavs Hospital, Trondheim, Norway.
  • Syndikus I; Clatterbridge Cancer Centre, Clatterbridge Health Park, Bebington, Wirral, UK.
  • Vogelzang NJ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
  • O'Bryan-Tear CG; Algeta ASA, Kjelsaas, Oslo, Norway.
  • Shan M; Bayer Healthcare, Whippany, NJ, USA.
  • Bruland ØS; Norwegian Radium Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Parker C; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK.
Lancet Oncol ; 15(7): 738-46, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24836273
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Rádio (Elemento) / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Rádio (Elemento) / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article